Form 4 for THC TENET HEALTHCARE CORP
Accepted 2023-06-06 00:00:00 ET · period of report 2023-06-02 · accession 0001209191-23-034775 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-06 | 2023-06-02 | THC | Arbour Paola M | EVP, CIO | S - Sale+OE | $75.22 | -38.6K | 33.0K | -54% | -$2.90M |
| DM | 2023-06-06 | 2023-06-02 | THC | Arbour Paola M | EVP, CIO | M - OptEx | $31.46 | +38.6K | 50.2K | +331% | +$1.21M |
| DM | 2023-06-06 | 2023-06-02 | THC | Arbour Paola M | EVP, CIO | M - OptEx | $31.46 | -38.6K | 0 | -100% | -$1.21M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-02 | S | D | 17,205 | $75.44 | 33,006 | D | — | — | (F2) The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $75.39 to $75.48. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-06-02 | M | A | 21,351 | $28.26 | 54,357 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-02 | M | A | 17,205 | $35.43 | 50,211 | D | — | — | |
| 4 | Common | Common Stock | 2023-06-02 | S | D | 21,351 | $75.05 | 33,006 | D | — | — | (F3) The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $74.98 to $75.26. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | 2019 February Performance Stock Options (Right to Buy) | 2023-06-02 | M | D | 21,351 | $28.26 | 0 | D | $28.26 · — to 2029-02-27 | 21,351 Common Stock | (F1) This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. (F5) These derivative securities (stock options) vested and became exercisable on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend). |
| 6 | Derivative | 2018 May Performance Stock Options (Right to Buy) | 2023-06-02 | M | D | 17,205 | $35.43 | 0 | D | $35.43 · — to 2028-05-31 | 17,205 Common Stock | (F1) This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. (F4) These derivative securities (stock options) vested and became exercisable on May 28, 2021 (the business day prior to May 31, 2021, which was a federal holiday). |